Qi Xia, Qinghua Ma, Jiuqun Zhu, Lu Gu, Fengling Zhou: Prognostic factors in postoperative patients with cutaneous melanoma: a systematic review and meta-analysis. Am J Cancer Res 2024;14(5):1947-1956. (Full text, PDF)
Shams GE Shams, Ron-Joseph Ocampo, Sanna Rahman, Maysoon M Makhlouf, Jihad Ali, Magdy M Elnashar, Hassan L Ebrahim, Zakaria Y Abd Elmageed: Decoding the secrets of small extracellular vesicle communications: exploring the inhibition of vesicle-associated pathways and interception strategies for cancer treatment. Am J Cancer Res 2024;14(5):1957-1980. (Full text, PDF)
Mengfei Sun, Pengjie Yang, Weisong Wang, Yongjun Yu, Dongdong Yang, Yaodong Ping, Benben Zhu: Advancements in the research of immune checkpoint inhibitors for the treatment of advanced esophageal squamous cell carcinoma. Am J Cancer Res 2024;14(5):1981-1998. (Full text, PDF)
Thaís C Muradás, Raquel DS Freitas, João IB Gonçalves, Fernando AC Xavier, Daniel R Marinowic: Potential antitumor effects of short-chain fatty acids in breast cancer models. Am J Cancer Res 2024;14(5):1999-2019. (Full text, PDF)
Jing Lan, Lei Wang, Jianbo Cao, Yuqiu Wan, Yehui Zhou: circBRAF promotes the progression of triple-negative breast cancer through modulating methylation by recruiting KDM4B to histone H3K9me3 and IGF2BP3 to mRNA. Am J Cancer Res 2024;14(5):2020-2036. (Full text, PDF)
Xiao-Li Zheng, Zhi-Di Li, Kai-Zhi Luo, Yang-Ling Li, Ye-Han Liu, Shu-Ying Shen, Fei-Yan Shen, Wan-Yan Li, Guo-Qing Chen, Chong Zhang, Ling-Hui Zeng: POLR2J expression promotes glioblastoma malignancy by regulating oxidative stress and the STAT3 signaling pathway. Am J Cancer Res 2024;14(5):2037-2054. (Full text, PDF)
Fengguang Zhai, Yuxuan Li, Xia Luo, Xiaofeng Jin, Meng Ye: NOLC1 was identified as a tumor suppressor gene in thyroid cancer and correlated with prognosis by bioinformatics. Am J Cancer Res 2024;14(5):2055-2071. (Full text, PDF)
Gui-Hong Li, Ying Miao, Huang Chen, Meng-Fei Xue, Jia-Yu Wang, Jing-Wen Zhang, Zheng-Fang Yi, Zhen-Liang Sun: The small-molecule drug homoharringtonine targets HSF1 to suppress pancreatic cancer progression. Am J Cancer Res 2024;14(5):2072-2087. (Full text, PDF)
Meibao Feng, Xuesong Wu, Jing Zhang, Pei Chen, Senmi Qian, Chengdong Chang: Loss of Lipocalin2 confers cisplatin vulnerability through modulating NF-ĸB mediated ferroptosis via ferroportin. Am J Cancer Res 2024;14(5):2088-2102. (Full text, PDF)
Po-An Chen, Pei-Ching Chang, Wayne W Yeh, Tze-Yun Hu, Yung-Chih Hong, Yu-Chao Wang, William J Huang, Tzu-Ping Lin: The lncRNA TPT1-AS1 promotes the survival of neuroendocrine prostate cancer cells by facilitating autophagy. Am J Cancer Res 2024;14(5):2103-2123. (Full text, PDF)
Fengbin Zhang, Xinran Zhang, Xin Zhang, Yingnan Wang, Tongkun Li, Honghai Guo, Ping’an Ding, Yuan Tian, Peigang Yang, Xiaolong Li, Ning Meng, Zhenjiang Guo, Qun Zhao, Ruixing Zhang: Recurrent metastatic patterns and prognosis after radical surgery in patients with alpha-fetoprotein-producing gastric cancer: a retrospective cohort study. Am J Cancer Res 2024;14(5):2124-2140. (Full text, PDF)
Sally Lien, Thomas P Whitbread, Shiva O Shastri, Jamie A Contreras, Ruiying Zhao, Yan Zhu: Cancer-associated MDM2 W329G mutant attenuates ribosomal stress-mediated p53 responses to promote cell survival and glycolysis. Am J Cancer Res 2024;14(5):2141-2156. (Full text, PDF)
Xiaoli Li, Nan Ding, Wenting Ma, Ming Zhang: IFIH1-mediated post-transcriptional regulation of PTTG1 promotes proliferation and affects PHA-848125 sensitivity and prognosis in oropharyngeal carcinoma. Am J Cancer Res 2024;14(5):2157-2171. (Full text, PDF)
Chih-Chien Wu, Chien-Chou Su, Pei-Ting Lee, Yu-Hsun Chen, Chao-Wen Hsu, Yi-Chia Su: Comparative effectiveness of primary tumor resection versus chemotherapy in patients with asymptomatic unresectable metastatic colorectal cancer: a retrospective cohort study using the target trial emulation framework. Am J Cancer Res 2024;14(5):2172-2186. (Full text, PDF)
Yun-Chieh Kao, Mu-Ying Yang, Wei-Shone Chen, Jeng-Kai Jiang, Huann-Sheng Wang, Shih-Ching Chang, Yuan-Tzu Lan, Chun-Chi Lin, Hung-Hsin Lin, Sheng-Chieh Huang, Hou-Hsuan Cheng, Yu-Zu Lin, Yi-Wen Yang, Hao-Wei Teng: The salvage lenvatinib-based regimen provides survival benefit in patients with refractory metastatic colorectal cancer. Am J Cancer Res 2024;14(5):2187-2201. (Full text, PDF)
Jiahao Jiang, Jinming Xu, Longhua Ou, Cong Yin, Yan Wang, Bentao Shi: ITM2A inhibits the progression of bladder cancer by downregulating the phosphorylation of STAT3. Am J Cancer Res 2024;14(5):2202-2215. (Full text, PDF, Table S1)
Zigeng Zhang, Guangbo Yu, Aydin Eresen, Qiaoming Hou, Vahid Yaghmai, Zhuoli Zhang: MRI monitoring of combined therapy with transcatheter arterial delivery of NK cells and systemic administration of sorafenib for the treatment of HCC. Am J Cancer Res 2024;14(5):2216-2227. (Full text, PDF)
Qiang Chen, Weiguo Zhang, Xiaopeng Wu, Shuchang Chen: Expression of circRNA-0036474 in esophageal cancer and its clinical significance. Am J Cancer Res 2024;14(5):2228-2239. (Full text, PDF)
Hirotaka Miyashita, Nicholas J Bevins, Kartheeswaran Thangathurai, Suzanna Lee, Sarabjot Pabla, Mary K Nesline, Sean T Glenn, Jeffrey M Conroy, Paul DePietro, Eitan Rubin, Jason K Sicklick, Shumei Kato, Razelle Kurzrock: The transcriptomic expression pattern of immune checkpoints shows heterogeneity between and within cancer types. Am J Cancer Res 2024;14(5):2240-2252. (Full text, PDF)
Su Yon Jung, Herbert Yu, Xianglong Tan, Matteo Pellegrini: Novel DNA methylation-based epigenetic signatures in colorectal cancer from peripheral blood leukocytes. Am J Cancer Res 2024;14(5):2253-2271. (Full text, PDF)
Ning Meng, Xiaoman Niu, Jiaxiang Wu, Haotian Wu, Tongkun Li, Jiaxuan Yang, Ping’an Ding, Honghai Guo, Yuan Tian, Peigang Yang, Zhidong Zhang, Dong Wang, Qun Zhao: Development and validation of nomogram models for predicting overall survival and cancer-specific survival in gastric cancer patients with liver metastases: a cohort study based on the SEER database. Am J Cancer Res 2024;14(5):2272-2286. (Full text, PDF)
Wen-Chien Huang, Hung-Tai Wu, Pei-Wen Yang, Chi-Jung Li, Yen-Su Huang, Hang Chang, Yu-Jen Chen: A 35-gene mutation profile predicts the therapeutic outcome of patients with esophageal squamous cell carcinoma receiving neo-adjuvant chemoradiation. Am J Cancer Res 2024;14(5):2287-2299. (Full text, PDF)
Szu-Wen Tseng, Wan-Ming Chen, An-Tzu Jao, Mingchih Chen, Ben-Chang Shia, Szu-Yuan Wu: Maintenance chemotherapy for esophageal squamous cell carcinoma after standard concurrent chemoradiotherapy: a national propensity score matching cohort study. Am J Cancer Res 2024;14(5):2300-2312. (Full text, PDF)
Szu-Wen Tseng, Wan-Ming Chen, Ben-Chang Shia, Ming-Chih Chen, Szu-Yuan Wu: Correlation of maintenance chemotherapy and improved survival in patients with locally advanced unresectable pancreatic head adenocarcinoma receiving neoadjuvant chemotherapy and concurrent chemoradiotherapy. Am J Cancer Res 2024;14(5):2313-2325. (Full text, PDF)
Tianze Li, Jianwei Yi, Huajun Wu, Kai Wang, Binghai Zhou: SLC7A11 in hepatocellular carcinoma: potential mechanisms, regulation, and clinical significance. Am J Cancer Res 2024;14(5):2326-2342. (Full text, PDF)
Zuoquan Zhu, Shikun Dong, Shaolei Qin, Ke Gu, Yanjun Zhou: ANOS1 accelerates the progression of esophageal cancer identified by multi-omic approaches. Am J Cancer Res 2024;14(5):2343-2370. (Full text, PDF)
Jiahua Zhao, Xuhui Yang, Wenwen Gong, Lin Zhang, Chenxi Li, Xiao Han, Yang Zhang, Xiangyang Chu: LINC00908 attenuates LUAD tumorigenesis through DEAD-box helicase 54. Am J Cancer Res 2024;14(5):2371-2389. (Full text, PDF)
Xin Gao, Ying Zhu, Tongdan Lv, Mingpeng Luo, Yu Jiang, Leitao Sun, Shusen Zheng, Donghai Jiang, Shanming Ruan: Resveratrol restrains colorectal cancer metastasis by regulating miR-125b-5p/TRAF6 signaling axis. Am J Cancer Res 2024;14(5):2390-2407. (Full text, PDF)
Jie Yang, Zuodong Ren, Fazhan Wang, Jun Zheng, Zhaowei Zhuang, Yan Zeng: γ-Synuclein promotes proliferation and inhibits apoptosis of oral squamous cell carcinoma via JAK2/STAT5b signaling pathway. Am J Cancer Res 2024;14(5):2408-2423. (Full text, PDF)
Yi-Hsin Tseng, Wen-Ru Chou, Wei-Lun Liu, Zhong-Xuan Dung, Ching-Hao Lin, Chia-Hung Hsieh, Chi-Chung Wang: Effects of methylation and transcription factor YY1 on ID2 expression in non-small cell lung carcinoma cells. Am J Cancer Res 2024;14(5):2424-2438. (Full text, PDF)
Bohang Chen, Bohao Zhang, María Begoña García Cenador: Human bone marrow mesenchymal stem cell-driven LncRNA PTCSC3 upregulation within lung adenocarcinoma cells reduces erlotinib resistance by mitigating Wnt/β-Catenin pathway. Am J Cancer Res 2024;14(5):2439-2452. (Full text, PDF)
Yiqun Zhang, Nikos Tapinos, Rishi Lulla, Wafik S El-Deiry: Dopamine pre-treatment impairs the anti-cancer effect of integrated stress response- and TRAIL pathway-inducing ONC201, ONC206 and ONC212 imipridones in pancreatic, colorectal cancer but not DMG cells. Am J Cancer Res 2024;14(5):2453-2464. (Full text, PDF)
Chien-Hung Chen, Jing-Houng Wang, Hsueh-Chou Lai, Tsung-Hui Hu, Chao-Hung Hung, Sheng-Nan Lu, Cheng-Yuan Peng: Mac-2 binding protein glycosylation isomer at 5 years of antiviral therapy predict hepatocellular carcinoma and mortality beyond year 5 in chronic hepatitis B patients with cirrhosis. Am J Cancer Res 2024;14(5):2465-2477. (Full text, PDF)
Juan Chen, Jingjing Huan, Chunyan Chen, Wenxia Xu, Aiqun Jia: Enhancing hospice care with psychological support and a nomogram to predict delirium in patients with advanced solid tumors. Am J Cancer Res 2024;14(5):2478-2492. (Full text, PDF)
Jibran Ahmed, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K Nesline, Sarabjot Pabla, Jeffrey M Conroy, Paul DePietro, Jason K Sicklick, Shumei Kato, Razelle Kurzrock: TIM-3 transcriptomic landscape with clinical and immunomic correlates in cancer. Am J Cancer Res 2024;14(5):2493-2506. (Full text, PDF)
Yunxiao Li, Qianqian Cui, Bin Zhou, Jiayu Zhang, Rong Guo, Yanyan Wang, Xinhua Xu: RSAD2, a pyroptosis-related gene, predicts the prognosis and immunotherapy response for colorectal cancer. Am J Cancer Res 2024;14(5):2507-2522. (Full text, PDF)
Li Yu, Zheling Chen, Ying Wu, Meiliang Xu, Difei Zhong, Hongen Xu, Wei Zhu: Unraveling role of ubiquitination in drug resistance of gynecological cancer. Am J Cancer Res 2024;14(5):2523-2537. (Full text, PDF)
Haiyue Zhu, Yuxin Bao, Xuanqi Dou, Xiaofeng Zuo, Junhong Ye, Haiyu Ma, Youquan Bu, Yitao Wang, Jiang Zhu: KIF2C is a critical regulator for malignant progression of head and neck squamous cell carcinoma. Am J Cancer Res 2024;14(5):2538-2554. (Full text, PDF)
Chung-Yu Chen, Wei-Jan Wang, Chen-Shiou Wu, Shao-Chun Wang, Wei-Chao Chang, Mien-Chie Hung: Tannic acids and proanthocyanidins in tea inhibit SARS-CoV-2 variants infection. Am J Cancer Res 2024;14(5):2555-2569. (Full text, PDF)
Yifan Li, Juying Kang, Xiaojuan Zhang: How to incorporate new agents into precise medicine for cholangiocarcinoma? Am J Cancer Res 2024;14(5):2570-2583. (Full text, PDF)
Xinyu Liu, Rui Miao, Kui Liu, Qun Xie, Penghui Zheng, Junai Zhu, Ying Zhang, Fusen Peng: Panoramic analysis of cell death patterns reveals prognostic and immune profiles of head and neck squamous cell carcinoma. Am J Cancer Res 2024;14(5):2584-2607. (Full text, PDF, Table S1)
Jintao Yu, Tianyu E, Mingliang Zhou, Jun Niu, Jinshen Wang, Ruizheng Miao, Cunjin Dong, Huijie Gao, Changqing Jing, Benjia Liang: Integrin αvβ6 mediates the immune escape through regulation of PD-L1 and serves as a novel marker for immunotherapy of colon carcinoma. Am J Cancer Res 2024;14(5):2608-2625. (Full text, PDF)
Yueyao Yang, Qian Huang, Mo Cheng, Lu Deng, Xun Liu, Xiufeng Zheng, Jing Wei, Yanna Lei, Xiaoyin Li, Fukun Guo, Yu Deng, Yi Zheng, Feng Bi, Gang Wang, Ming Liu: Efficacy and advantage of immunotherapy for melanoma via intramuscular co-expression of plasmid-encoded PD-1 and CTLA-4 scFvs. Am J Cancer Res 2024;14(5):2626-2642. (Full text, PDF)
Qianlong Meng, Wei Zheng, Ruili Jiao, Ran Cui, Yunhan Deng, Ruizhen Liu, Jing Wang, Huimin Bai: MicroRNA 421 induces the formation of high-invasive cell subsets of ovarian cancer from low-invasive cell subsets mediated by exosomes by activating the PI3K/AKT pathway. Am J Cancer Res 2024;14(5):2643-2660. (Full text, PDF)
Xiaochen Qi, Jin Wang, Xiangyu Che, Quanlin Li, Xiaowei Li, Qifei Wang, Guangzhen Wu: The potential value of cuprotosis (copper-induced cell death) in the therapy of clear cell renal cell carcinoma: Am J Cancer Res. 2022; 12(8): 3947-3966. Am J Cancer Res 2024;14(5):2661-2664. (Full text, PDF)
Joanna Wesoly, Natalia Pstrąg, Kamil Derylo, Barbara Michalec-Wawiórka, Natalia Derebecka, Hanna Nowicka, Arkadiusz Kajdasz, Katarzyna Kluzek, Malgorzata Srebniak, Marek Tchórzewski, Zbigniew Kwias, Hans Bluyssen: Structural, topological, and functional characterization of transmembrane proteins TMEM213, 207, 116, 72 and 30B provides a potential link to ccRCC etiology: Am J Cancer Res. 2023; 13(5): 1863-1883. Am J Cancer Res 2024;14(5):2665. (Full text, PDF)
